[The safety of 5-phosphodiesterase inhibitors in the treatment of erectile dysfunction in patients with cardiovascular disease].;Bezpieczeństwo stosowania inhibitorów 5-fosfodiesterazy w leczeniu zaburzeń erekcji u pacjentów z chorobami układu krazenia.

Przegla̧d lekarski

Volumn 66, Issue 4, 2009, Pages 192-197

  Bryniarski, Leszek ^a   Rzepecki, Maciej ^b   Klocek, Marek ^b   Wyczołkowski, Marek ^b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE INHIBITOR;

AGED; CARDIOVASCULAR DISEASE; COMORBIDITY; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG INTERACTION; ERECTILE DYSFUNCTION; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; REVIEW; RISK ASSESSMENT; VASODILATATION;

AGED; CARDIOVASCULAR DISEASES; COMORBIDITY; CORONARY ARTERY DISEASE; DRUG INTERACTIONS; ERECTILE DYSFUNCTION; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; PREVALENCE; RISK ASSESSMENT; VASODILATION;

EID: 79958183690     PISSN: 00332240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)